Developer docs
API playgroundTry for free, no card

Search company profiles

d9 Designs

Full company profile

uuid000jdct

Namestring
d9 Designs
Legal namestring
d9 Designs Inc.
Websiteurl
d9designs.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

d9 Designs Inc. is a privately held consumer products and ingredient-licensing company (founded and headquartered in Concord, MA) operating as a commercialization subsidiary of Lennham Pharmaceuticals, Inc. Its core technology is d9-Caffeine — a patented deuterated form of caffeine in which 9 of 10 hydrogen atoms are replaced with deuterium — engineered into two proprietary ingredient brands: Deura9 for ingestible applications (pre-workout, functional beverages, energy) and Elustra for topical skincare applications. The technology is differentiated at the molecular level rather than via formulation tricks, with peer-reviewed clinical evidence supporting 3x longer duration of effect, 5–10x lower exposure to primary caffeine metabolites, smoother energy delivery, and improved topical stability relative to conventional caffeine.

The company operates a dual commercialization model. On the B2B side, it licenses d9-Caffeine to consumer brands — most notably an exclusive agreement with Nutrabolt covering the powdered pre-workout category, which yielded the May 2025 launch of C4 AlphaBomb ($54.99 retail price, distributed across 125+ countries via DTC, Amazon, and major U.S. retailers). On the B2C side, the company is building two owned brands: Derma9 skincare (powered by Elustra, with Eye-Volution eye serum as the lead SKU, target launch Q1 2026) and Deuzy energy shots (powered by Deura9, target launch Q1 2027). The IP estate comprises 4 issued U.S. patents with protection through 2039, plus GRAS regulatory clearance obtained in June 2024 enabling U.S. food, beverage, and cosmetic applications.

Customer end-markets span performance nutrition consumers (athletes seeking crash-free energy), energy-product consumers (those sensitive to conventional caffeine metabolites), and skincare consumers (anti-aging, hydration), with B2B brand partners serving as a secondary channel. Pricing for licensing and ingredient sales is quote-based; consumer retail pricing on the Nutrabolt partner SKU is $54.99. Revenue figures are not publicly disclosed, and the team is described as 1–10 employees with leadership including Co-CEO Brad Sippy (inventor on 17 issued U.S. patents, prior $110M Tremeau raise), Co-CEO Jeffrey Wren (ex-UCB, ex-BioSerenity), CSO Bruce Lavin MD/MPH (ex-Sanofi, Novartis, BMS, UCB), CCO Joshua Wren, and CFO Rusty Rohrbaugh, CFA.

Short descriptiontext

d9 Designs Inc. is a privately held ingredient and consumer products company that develops and licenses patented deuterated caffeine (d9-Caffeine) under sub-brands Deura9 (ingestible) and Elustra (topical), serving performance nutrition, energy, and skincare brands via B2B licensing and forthcoming owned brands Derma9 and Deuzy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersConcord, United States
HQ citystring
Concord
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty chemical ingredients, deuterated caffeine technology, performance nutrition licensing, cosmetic active ingredients, functional beverage additives
Industry4 codes
PRIMARYCRADAHAJ
Energy Drinks & Energy Shots
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Non-Alcoholic Beverages (Coffee, Tea, Soft Drinks, Water)
SECONDARYCRADAHAL
Functional Beverages (Vitamins, Probiotics, Nootropics, etc.)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Non-Alcoholic Beverages (Coffee, Tea, Soft Drinks, Water)
SECONDARYAFAFAFAI
Functional Shot Production (Wellness/Immunity/Focus Shots)
Agriculture & Food Production/Beverage Production/Functional & Nutritional Beverage Production (Energy, Sports, Fortified)
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
NAICS code1 code
  • Food Manufacturing311
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Specialty Chemical Ingredients
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Technology Licensing
TypeLicensing Royalties
Description

d9 Designs licenses its patented d9-Caffeine technology to brands across distinct verticals including pre-workout supplements, functional beverages, and cosmetics. The exclusive licensing agreement with Nutrabolt for powdered pre-workout space represents the first commercial application.

d9designs.com
2Own Branded Products
TypeOne Time License
Description

Development and commercialization of proprietary brands including Derma9 skincare (powered by Elustra, launching Q1 2026) and Deuzy energy shots (powered by Deura9, launching Q1 2027), sold through direct-to-consumer and retail channels.

d9designs.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1C4 AlphaBomb pre-workout containing Deura9
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$54.99 per container, available at www.cellucor.com and leading retailers

d9designs.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Derma9™
Description

d9-Caffeine focused skincare brand delivering prolonged firming and wrinkle-smoothing benefits with Elustra technology. Estimated Launch: Q1 2026.

d9designs.com
+1 more record
Core offering1 text field

d9 Designs develops, manufactures, and licenses d9-Caffeine (deuterated caffeine), a patented ingredient in which 9 of 10 hydrogen atoms are replaced with deuterium to deliver longer-lasting, smoother caffeine effects. The technology is offered in two forms — Deura9 for ingestible applications (pre-workout supplements, functional beverages, energy shots) and Elustra for topical skincare — and is commercialized both through B2B ingredient licensing deals with consumer brands (e.g., exclusive Nutrabolt deal for C4 pre-workout) and through the company's own branded consumer product lines (Derma9 skincare, Deuzy energy shots, Eye-Volution eye serum).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 3x longer duration of stimulatory effects compared to ordinary caffeine
+5 more records
Product overview1 text field

d9 Designs is a consumer products manufacturer that has developed d9-Caffeine (deuterated caffeine) technology — the first major innovation in the caffeine molecule. The company's portfolio includes two proprietary ingredient brands: Deura9™ for ingestible applications (energy, pre-workout, functional beverages) and Elustra™ for topical skincare applications. d9 Designs commercializes its technology through two branded product lines — Derma9™ skincare (launching Q1 2026) and Deuzy™ energy shots (launching Q1 2027) — as well as through licensing partnerships with industry leaders like Nutrabolt (C4 pre-workout products).

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-05-07
Description

Exclusive licensing agreement granting Nutrabolt rights to utilize patented Deura9 (d9-Caffeine) in the powdered pre-workout supplement space. Nutrabolt is a global leader in performance nutrition and owner of C4, the #1 selling global pre-workout brand. The first commercial product, C4 AlphaBomb, launched May 10, 2025, containing 336mg caffeine complex including Deura9 for explosive sensory experience. Nutrabolt's portfolio is distributed in over 125 countries through DTC, Amazon, and major retailers.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Featured partner brand for first commercial application of Deura9 technology. C4 AlphaBomb pre-workout is the first product on the market harnessing the power of Deura9, setting a new standard for the pre-workout category.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Celsius is a public functional energy drink company with science-driven positioning, premium pricing, and multi-channel distribution (DTC, convenience, fitness retail) — closely comparable to d9 Designs' energy shot/pre-workout commercialization strategy and target consumer.

2Alani Nu
TypeDirect peer
Description

Alani Nu is a fast-growing functional energy and nutrition brand with strong female consumer pull and DTC-plus-retail distribution; mirrors d9 Designs' combination of branded consumer launch with founder-led, science-marketed positioning.

TypeDirect peer
Description

Bloom is a functional beverage and greens brand targeting female consumers with a social/DTC-led go-to-market model — comparable to d9 Designs' planned Deuzy energy shot launch in target demographic and channel mix.

4Monster Beverage Corporation
TypeBroad incumbent
Description

Monster is the dominant global energy drink incumbent with broad SKU coverage of the energy drink category that d9 Designs' Deura9/Deuzy ultimately compete in, although at vastly different scale.

TypeBroad incumbent
Description

Red Bull is the brand-defining energy drink incumbent, anchoring the caffeine-energy consumer category that d9 Designs' technology platform serves through licensing and branded entries.

TypeDirect peer
Description

The Ordinary is a science-forward, ingredient-centric skincare brand with caffeine-based eye/topical SKUs; compares to d9 Designs' Derma9 / Eye-Volution skincare launch with similar ingredient-first, clinical-evidence marketing approach.

TypeOthers
Description

Nutrabolt is d9 Designs' anchor licensing partner and category leader in pre-workout; treated as a peer given overlapping pre-workout/caffeine category exposure rather than a direct competitor.

TypeBroad incumbent
Description

Keurig Dr Pepper is a large incumbent in caffeinated beverages (coffee, energy, soft drinks); a potential strategic acquirer/partner for d9-Caffeine across multiple consumer verticals and a benchmark for category scale.

TypeBroad incumbent
Description

Olay is a mainstream skincare brand with multiple caffeine-containing anti-aging SKUs; a direct competitor to Derma9 in retail skincare channels despite very different scale.

TypeBroad incumbent
Description

La Roche-Posay is a dermo-cosmetic leader positioned on clinical efficacy and tolerability — closely analogous to Derma9's dermatological, clinically validated skincare positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

d9 Designs

Specialty Chemical Ingredientsd9designs.com

d9 Designs Inc. is a privately held ingredient and consumer products company that develops and licenses patented deuterated caffeine (d9-Caffeine) under sub-brands Deura9 (ingestible) and Elustra (topical), serving performance nutrition, energy, and skincare brands via B2B licensing and forthcoming owned brands Derma9 and Deuzy.

What d9 Designs does

d9 Designs Inc. is a privately held consumer products and ingredient-licensing company (founded and headquartered in Concord, MA) operating as a commercialization subsidiary of Lennham Pharmaceuticals, Inc. Its core technology is d9-Caffeine — a patented deuterated form of caffeine in which 9 of 10 hydrogen atoms are replaced with deuterium — engineered into two proprietary ingredient brands: Deura9 for ingestible applications (pre-workout, functional beverages, energy) and Elustra for topical skincare applications. The technology is differentiated at the molecular level rather than via formulation tricks, with peer-reviewed clinical evidence supporting 3x longer duration of effect, 5–10x lower exposure to primary caffeine metabolites, smoother energy delivery, and improved topical stability relative to conventional caffeine.

The company operates a dual commercialization model. On the B2B side, it licenses d9-Caffeine to consumer brands — most notably an exclusive agreement with Nutrabolt covering the powdered pre-workout category, which yielded the May 2025 launch of C4 AlphaBomb ($54.99 retail price, distributed across 125+ countries via DTC, Amazon, and major U.S. retailers). On the B2C side, the company is building two owned brands: Derma9 skincare (powered by Elustra, with Eye-Volution eye serum as the lead SKU, target launch Q1 2026) and Deuzy energy shots (powered by Deura9, target launch Q1 2027). The IP estate comprises 4 issued U.S. patents with protection through 2039, plus GRAS regulatory clearance obtained in June 2024 enabling U.S. food, beverage, and cosmetic applications.

Customer end-markets span performance nutrition consumers (athletes seeking crash-free energy), energy-product consumers (those sensitive to conventional caffeine metabolites), and skincare consumers (anti-aging, hydration), with B2B brand partners serving as a secondary channel. Pricing for licensing and ingredient sales is quote-based; consumer retail pricing on the Nutrabolt partner SKU is $54.99. Revenue figures are not publicly disclosed, and the team is described as 1–10 employees with leadership including Co-CEO Brad Sippy (inventor on 17 issued U.S. patents, prior $110M Tremeau raise), Co-CEO Jeffrey Wren (ex-UCB, ex-BioSerenity), CSO Bruce Lavin MD/MPH (ex-Sanofi, Novartis, BMS, UCB), CCO Joshua Wren, and CFO Rusty Rohrbaugh, CFA.

d9 Designs firmographics

Firmographics
Name
d9 Designs
Legal name
d9 Designs Inc.
Website
https://d9designs.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
d9 Designs Inc. is a privately held ingredient and consumer products company that develops and licenses patented deuterated caffeine (d9-Caffeine) under sub-brands Deura9 (ingestible) and Elustra (topical), serving performance nutrition, energy, and skincare brands via B2B licensing and forthcoming owned brands Derma9 and Deuzy.
Ownership category
akta.pro rank

d9 Designs industry classification

Industry
Product category
Specialty Chemical Ingredients
NAICS
Food Manufacturing (311)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAHAJ
Energy Drinks & Energy Shots
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Non-Alcoholic Beverages (Coffee, Tea, Soft Drinks, Water)
SECONDARYCRADAHAL
Functional Beverages (Vitamins, Probiotics, Nootropics, etc.)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Non-Alcoholic Beverages (Coffee, Tea, Soft Drinks, Water)
SECONDARYAFAFAFAI
Functional Shot Production (Wellness/Immunity/Focus Shots)
Agriculture & Food Production/Beverage Production/Functional & Nutritional Beverage Production (Energy, Sports, Fortified)
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare

Keywords

  • Specialty chemical ingredients
  • Deuterated caffeine technology
  • Performance nutrition licensing
  • Cosmetic active ingredients
  • Functional beverage additives

Where d9 Designs is headquartered

Location

Headquarters

HQ city
Concord
HQ country
United States
HQ region
North America

Offices1 record

Markets served

d9 Designs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Technology Licensing: d9 Designs licenses its patented d9-Caffeine technology to brands across distinct verticals including pre-workout supplements, functional beverages, and cosmetics. The exclusive licensing agreement with Nutrabolt for powdered pre-workout space represents the first commercial application.
  2. Own Branded Products: Development and commercialization of proprietary brands including Derma9 skincare (powered by Elustra, launching Q1 2026) and Deuzy energy shots (powered by Deura9, launching Q1 2027), sold through direct-to-consumer and retail channels.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goC4 AlphaBomb pre-workout containing Deura9

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

d9 Designs product offering

Product offering

Core offering

d9 Designs develops, manufactures, and licenses d9-Caffeine (deuterated caffeine), a patented ingredient in which 9 of 10 hydrogen atoms are replaced with deuterium to deliver longer-lasting, smoother caffeine effects. The technology is offered in two forms — Deura9 for ingestible applications (pre-workout supplements, functional beverages, energy shots) and Elustra for topical skincare — and is commercialized both through B2B ingredient licensing deals with consumer brands (e.g., exclusive Nutrabolt deal for C4 pre-workout) and through the company's own branded consumer product lines (Derma9 skincare, Deuzy energy shots, Eye-Volution eye serum).

Product overview

d9 Designs is a consumer products manufacturer that has developed d9-Caffeine (deuterated caffeine) technology — the first major innovation in the caffeine molecule. The company's portfolio includes two proprietary ingredient brands: Deura9™ for ingestible applications (energy, pre-workout, functional beverages) and Elustra™ for topical skincare applications. d9 Designs commercializes its technology through two branded product lines — Derma9™ skincare (launching Q1 2026) and Deuzy™ energy shots (launching Q1 2027) — as well as through licensing partnerships with industry leaders like Nutrabolt (C4 pre-workout products).

Differentiator

Problem solved

Functional benefit

Brands

  • Derma9™: d9-Caffeine focused skincare brand delivering prolonged firming and wrinkle-smoothing benefits with Elustra technology. Estimated Launch: Q1 2026.
  • Deuzy™

Quantifiable outcome

  • 3x longer duration of stimulatory effects compared to ordinary caffeine
  • +5 more outcomes

Companies that use d9 Designs

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles2 records

d9 Designs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

d9 Designs partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship and core.

  • NutraboltflagshipOEM/ Whitelabel/ Licensing Partner · 7 May 2025Exclusive licensing agreement granting Nutrabolt rights to utilize patented Deura9 (d9-Caffeine) in the powdered pre-workout supplement space. Nutrabolt is a global leader in performance nutrition and owner of C4, the #1 selling global pre-workout brand. The first commercial product, C4 AlphaBomb, launched May 10, 2025, containing 336mg caffeine complex including Deura9 for explosive sensory experience. Nutrabolt's portfolio is distributed in over 125 countries through DTC, Amazon, and major retailers.
  • C4 Energy (Nutrabolt Brand)coreOEM/ Whitelabel/ Licensing PartnerFeatured partner brand for first commercial application of Deura9 technology. C4 AlphaBomb pre-workout is the first product on the market harnessing the power of Deura9, setting a new standard for the pre-workout category.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

d9 Designs competitors and assessment

Company assessment

Direct peers

  • Celsius Holdings: Celsius is a public functional energy drink company with science-driven positioning, premium pricing, and multi-channel distribution (DTC, convenience, fitness retail) — closely comparable to d9 Designs' energy shot/pre-workout commercialization strategy and target consumer.
  • Alani Nu: Alani Nu is a fast-growing functional energy and nutrition brand with strong female consumer pull and DTC-plus-retail distribution; mirrors d9 Designs' combination of branded consumer launch with founder-led, science-marketed positioning.
  • Bloom Nutrition: Bloom is a functional beverage and greens brand targeting female consumers with a social/DTC-led go-to-market model — comparable to d9 Designs' planned Deuzy energy shot launch in target demographic and channel mix.
  • DECIEM / The Ordinary: The Ordinary is a science-forward, ingredient-centric skincare brand with caffeine-based eye/topical SKUs; compares to d9 Designs' Derma9 / Eye-Volution skincare launch with similar ingredient-first, clinical-evidence marketing approach.

Broad incumbents

  • Monster Beverage Corporation: Monster is the dominant global energy drink incumbent with broad SKU coverage of the energy drink category that d9 Designs' Deura9/Deuzy ultimately compete in, although at vastly different scale.
  • Red Bull: Red Bull is the brand-defining energy drink incumbent, anchoring the caffeine-energy consumer category that d9 Designs' technology platform serves through licensing and branded entries.
  • Keurig Dr Pepper: Keurig Dr Pepper is a large incumbent in caffeinated beverages (coffee, energy, soft drinks); a potential strategic acquirer/partner for d9-Caffeine across multiple consumer verticals and a benchmark for category scale.
  • Olay (Procter & Gamble): Olay is a mainstream skincare brand with multiple caffeine-containing anti-aging SKUs; a direct competitor to Derma9 in retail skincare channels despite very different scale.
  • La Roche-Posay (L'Oréal): La Roche-Posay is a dermo-cosmetic leader positioned on clinical efficacy and tolerability — closely analogous to Derma9's dermatological, clinically validated skincare positioning.

Others

  • Nutrabolt (C4): Nutrabolt is d9 Designs' anchor licensing partner and category leader in pre-workout; treated as a peer given overlapping pre-workout/caffeine category exposure rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

d9 Designs social profiles

Digital presence

d9 Designs compliance and trust

Trust signal

Compliance1 record

d9 Designs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

d9 Designs leadership team

Management profile

Number of profiles

Profiles5 records

d9 Designs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

d9 Designs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about d9 Designs

What does d9 Designs do?

d9 Designs develops, manufactures, and licenses d9-Caffeine (deuterated caffeine), a patented ingredient in which 9 of 10 hydrogen atoms are replaced with deuterium to deliver longer-lasting, smoother caffeine effects. The technology is offered in two forms — Deura9 for ingestible applications (pre-workout supplements, functional beverages, energy shots) and Elustra for topical skincare — and is commercialized both through B2B ingredient licensing deals with consumer brands (e.g., exclusive Nutrabolt deal for C4 pre-workout) and through the company's own branded consumer product lines (Derma9 skincare, Deuzy energy shots, Eye-Volution eye serum).

Is d9 Designs a public or private company?

d9 Designs is a private company. It is classified as corporate owned and is currently operating.

When was d9 Designs founded?

d9 Designs was founded in 2019. It employs 1 to 10 people.

Where is d9 Designs based?

d9 Designs is headquartered in Concord, United States, in the North America region.

How does d9 Designs make money?

Two revenue lines are on record. Technology Licensing is the primary driver. The others are own Branded Products.

Who are d9 Designs's main competitors?

Direct peers on record are Celsius Holdings, Alani Nu, Bloom Nutrition and DECIEM / The Ordinary. Broad incumbents are Monster Beverage Corporation, Red Bull, Keurig Dr Pepper, Olay (Procter & Gamble) and La Roche-Posay (L'Oréal). Nutrabolt (C4) is listed as an others.

Does d9 Designs have an API?

No public API is recorded for d9 Designs.

What industry is d9 Designs in?

d9 Designs's product category is Specialty Chemical Ingredients. Its primary akta.pro industry code is CRADAHAJ, Energy Drinks & Energy Shots, with a secondary code of CRADAHAL, Functional Beverages (Vitamins, Probiotics, Nootropics, etc.). Its NAICS code is 311 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals